First Horizon Advisors’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$21.1K Sell
1,824
-927
-34% -$8.45K ﹤0.01% 1398
2025
Q1
$24K Sell
2,751
-315
-10% -$3.97K ﹤0.01% 1253
2024
Q4
$44K Buy
3,066
+156
+5% +$2.46K ﹤0.01% 1001
2024
Q3
$65.7K Buy
2,910
+1,012
+53% +$20.9K ﹤0.01% 868
2024
Q2
$36.9K Buy
1,898
+808
+74% +$21.2K ﹤0.01% 1056
2024
Q1
$40.9K Buy
1,090
+244
+29% +$10.7K ﹤0.01% 1053
2023
Q4
$47.3K Buy
846
+60
+8% +$2.61K ﹤0.01% 961
2023
Q3
$32.4K Sell
786
-277
-26% -$14.4K ﹤0.01% 1058
2023
Q2
$59.4K Sell
1,063
-421
-28% -$22.8K ﹤0.01% 817
2023
Q1
$82.8K Sell
1,484
-141
-9% -$6.58K ﹤0.01% 703
2022
Q4
$59.2K Buy
1,625
+405
+33% +$13.2K ﹤0.01% 794
2022
Q3
$34K Buy
1,220
+476
+64% +$18.1K ﹤0.01% 1005
2022
Q2
$33K Buy
744
+739
+14,780% +$38.3K ﹤0.01% 1096
2022
Q1
$0 Sell
5
-311
-98% -$27.2K ﹤0.01% 2274
2021
Q4
$46K Buy
316
+19
+6% +$2.91K ﹤0.01% 953
2021
Q3
$43K Buy
297
+63
+27% +$10.8K ﹤0.01% 973
2021
Q2
$45K Buy
234
+117
+100% +$21.2K ﹤0.01% 827
2021
Q1
$20K Buy
+117
New +$20.2K ﹤0.01% 1082

Other funds holding TXG

First Horizon Advisors's TXG Position: Q2 2025 in Review

First Horizon Advisors reduced its 10x Genomics (TXG) stake by 34% in Q2 2025, selling an estimated $8.45K and leaving 1,824 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

First Horizon Advisors first reported a position in TXG in Q1 2021 and has held it in 18 quarters since. The position peaked at $82.8K in Q1 2023. 297 funds tracked by Wall St. Rank hold TXG as of Q2 2025.

  • First Horizon Advisors held 1,824 shares of 10x Genomics worth $21.1K as of Q2 2025.
  • First Horizon Advisors sold 927 10x Genomics shares in Q2 2025, an estimated $8.45K.
  • 10x Genomics made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1398 holding.
  • First Horizon Advisors first reported a position in 10x Genomics in Q1 2021 and has held it in 18 quarters since.
  • First Horizon Advisors's 10x Genomics position peaked at $82.8K in Q1 2023.
  • 297 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.